(Q50574695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Adrian M. Di Bisceglie

9

object named as

Adrian M Di Bisceglie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Gregory T Everson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

John C Hoefs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Leonard B Seeff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Herbert L Bonkovsky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Deepa Naishadham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Mitchell L Shiffman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Jeffrey A Kahn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Anna S F Lok

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

William M Lee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Marc G Ghany

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Chihiro Morishima

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

HALT-C Trial Group

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

1675-1684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133499%20AND%20SRC:MED&resulttype=core&format=json

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

22 December 2019

cites work

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

7 January 2021

Epidemiology of hepatitis C

1 reference

7 January 2021

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

1 reference

7 January 2021

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

7 January 2021

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

7 January 2021

The natural history of hepatitis C.

1 reference

7 January 2021

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

1 reference

7 January 2021

Hepatocellular carcinoma: recent trends in the United States

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

1 reference

7 January 2021

Management of cirrhosis due to chronic hepatitis C.

1 reference

7 January 2021

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

7 January 2021

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

1 reference

7 January 2021

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

1 reference

7 January 2021

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

1 reference

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

7 January 2021

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

1 reference

7 January 2021